{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:47:34Z","timestamp":1792036054955,"version":"4.4.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish Research Council\/Vetenskapsr\u00e5det","award":["2017-00359"],"award-info":[{"award-number":["2017-00359"]}]},{"name":"Innovative Medicines Initiative project RTCure","award":["772209"],"award-info":[{"award-number":["772209"]}]},{"name":"Knut and Alice Wallenberg Foundation and King Gustaf V Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Individuals positive for anti-cyclic-peptide-antibodies (anti-CCP) and musculoskeletal complaints (MSK-C) are at risk for developing rheumatoid arthritis (RA). In this study we aimed to investigate factors involved in arthritis progression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Anti-CCP2-positive individuals with MSK-C referred to a rheumatologist were recruited. Individuals lacked arthritis at clinical and ultrasound examination and were followed for \u22653\u2009years or until clinical arthritis diagnosis. Blood samples from inclusion were analysed for nine ACPA reactivities (citrullinated \u03b1-1-enolase, fibrinogen, filaggrin, histone, vimentin and tenascin peptides); 92 inflammation-associated proteins; and HLA-shared epitope alleles. Cox regression was applied to the data to identify independent predictors in a model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Two hundred and sixty-seven individuals were included with median follow-up of 49\u2009months (interquartile range [IQR]: 22\u201360); 101 (38%) developed arthritis after a median of 14\u2009months (IQR: 6\u201327). The analysis identified that presence of at least one ACPA reactivity (hazard ratio [HR] 8.0; 95% CI: 2.9, 22), ultrasound-detected tenosynovitis (HR 3.4; 95% CI: 2.0, 6.0), IL-6 levels (HR 1.5; 95% CI: 1.2, 1.8) and IL-15 receptor \u03b1 (IL-15R\u03b1) levels (HR 0.6; 95% CI: 0.4, 0.9) are significant independent predictors for arthritis progression in a prediction model (Harrell\u2019s C 0.76 [s.e. 0.02], AUC 0.82 [95% CI: 0.76, 0.89], cross-validated AUC 0.70 [95% CI: 0.56, 0.85]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We propose a high RA risk phase characterized by presence of ACPA reactivity, tenosynovitis, IL-6 and IL-15R\u03b1 and suggest that these factors need to be further investigated for their biological effects and clinical values, to identify individuals at particular low risk and high risk for arthritis progression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae146","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T19:26:23Z","timestamp":1709925983000},"page":"3164-3171","source":"Crossref","is-referenced-by-count":20,"title":["Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis\u2014a prospective cohort study"],"prefix":"10.1093","volume":"63","author":[{"given":"Alexandra","family":"C\u00eerciumaru","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Rheumatology, Academic Specialist Center, Stockholm Health Services , Region Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-1629","authenticated-orcid":false,"given":"Yogan","family":"Kisten","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hansson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Thermo Fisher Scientific , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mathsson-Alm","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-8180","authenticated-orcid":false,"given":"Vijay","family":"Joshua","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"W\u00e4h\u00e4maa","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Loberg Haarhaus","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Padyukov","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu-Bogdan","family":"Catrina","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Diabetes, Academic Specialist Centrum , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Fei","sequence":"additional","affiliation":[{"name":"Center for Rheumatology, Academic Specialist Center, Stockholm Health Services , Region Stockholm"},{"name":"Swedish Medical Products Agency , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Vivar","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"af Klint","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Antovic","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Rheumatology, Academic Specialist Center, Stockholm Health Services , Region Stockholm"},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"R\u00e9thi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca I","family":"Catrina","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Rheumatology, Academic Specialist Center, Stockholm Health Services , Region Stockholm"},{"name":"Department of Rheumatology, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-3777","authenticated-orcid":false,"given":"Aase","family":"Hensvold","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Rheumatology, Academic Specialist Center, Stockholm Health Services , Region Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"2024110419213018800_keae146-B1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","article-title":"Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins","volume":"74","author":"Hensvold","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","article-title":"Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset","volume":"81","author":"Saevarsdottir","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.38927","article-title":"To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?","volume":"67","author":"Jiang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2024110419213018800_keae146-B4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024110419213018800_keae146-B5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","article-title":"Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis","volume":"65","author":"Brink","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024110419213018800_keae146-B6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024110419213018800_keae146-B7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ard.2007.073825","article-title":"Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors","volume":"67","author":"J\u00f8rgensen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/annrheumdis-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"2024110419213018800_keae146-B13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard-2022-223417","article-title":"Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development","volume":"82","author":"Raposo","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2013-204543","article-title":"IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies","volume":"74","author":"Laurent","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.38273","article-title":"Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis","volume":"66","author":"de Hair","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024110419213018800_keae146-B16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.2010.139527","article-title":"Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase","volume":"70","author":"van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3899\/jrheum.181095","article-title":"OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On","volume":"46","author":"Bruyn","year":"2019","journal-title":"J Rheumatol"},{"key":"2024110419213018800_keae146-B18","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1186\/ar4039","article-title":"Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides","volume":"14","author":"Hansson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2024110419213018800_keae146-B19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024110419213018800_keae146-B20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.compbiomed.2014.11.015","article-title":"A leave-one-out cross-validation SAS macro for the identification of markers associated with survival","volume":"57","author":"Rushing","year":"2015","journal-title":"Comput Biol Med"},{"key":"2024110419213018800_keae146-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Medicine"},{"key":"2024110419213018800_keae146-B22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-220546","article-title":"Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis","volume":"81","author":"Wouters","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","article-title":"The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia","volume":"70","author":"van de Stadt","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B24","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"2024110419213018800_keae146-B25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03009742.2020.1818820","article-title":"Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain","volume":"50","author":"Eloff","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2024110419213018800_keae146-B26","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419213018800_keae146-B27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41402","article-title":"Third-generation anti\u2013cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis","volume":"72","author":"Di Matteo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2024110419213018800_keae146-B28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/eji.201747446","article-title":"Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: implications for B-cell selection","volume":"48","author":"Lloyd","year":"2018","journal-title":"Eur J Immunol"},{"key":"2024110419213018800_keae146-B29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B30","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002705","article-title":"Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk","volume":"9","author":"Sokolova","year":"2023","journal-title":"RMD Open"},{"key":"2024110419213018800_keae146-B31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cei.13591","article-title":"Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients","volume":"204","author":"Roos Ljungberg","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"2024110419213018800_keae146-B32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"Kokkonen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024110419213018800_keae146-B33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2010.09.003","article-title":"Role of IL-15 in immune-mediated and infectious diseases","volume":"22","author":"Di Sabatino","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024110419213018800_keae146-B34","doi-asserted-by":"crossref","first-page":"155258","DOI":"10.1016\/j.cyto.2020.155258","article-title":"Interleukin-15 in autoimmunity","volume":"136","author":"Allard-Chamard","year":"2020","journal-title":"Cytokine"},{"key":"2024110419213018800_keae146-B35","first-page":"60","article-title":"Safety and efficacy of a human monoclonal antibody to IL-15 (AMG 714) in patients with rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"65","author":"I McInnes","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B36","doi-asserted-by":"crossref","first-page":"653994","DOI":"10.3389\/fmed.2021.653994","article-title":"Bone erosions detected by ultrasound are prognostic for clinical arthritis development in patients with ACPA and musculoskeletal pain","volume":"8","author":"Ziegelasch","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2024110419213018800_keae146-B37","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/annrheumdis-2015-208138","article-title":"Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis","volume":"75","author":"van Steenbergen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/kep136","article-title":"Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritis","volume":"48","author":"Eshed","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419213018800_keae146-B39","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/rheumatology\/keab830","article-title":"During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: a large imaging study in patients with clinically suspect arthralgia","volume":"61","author":"van Dijk","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419213018800_keae146-B40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/art.42320","article-title":"Combination of two monoclonal ACPAs induced tenosynovitis, pain and bone loss in mice in a Peptidyl Arginine Deiminase-4 dependent manner","volume":"75","author":"Krishnamurthy","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024110419213018800_keae146-B41","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/art.42552","article-title":"Reply","volume":"75","author":"Krishnamurthy","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024110419213018800_keae146-B42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2020-217215","article-title":"Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis","volume":"79","author":"Di Matteo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024110419213018800_keae146-B43","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/rheumatology\/keaa790","article-title":"Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease","volume":"60","author":"Lamacchia","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae146\/57282759\/keae146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3164\/60415441\/keae146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3164\/60415441\/keae146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T19:21:55Z","timestamp":1730748115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/11\/3164\/7624630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,3,8]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae146","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,3,8]]}}}